Stopped
Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance · Obesity or Overweight With Weight-Related Comorbidities
Trial terminated
Also in this update: Final enrollment: 8 participants — 7% of the 120 planned; Primary completion date changed from estimate of Nov 30, 2026 to Sep 11, 2026
Verdiva Bio Dev LimitedPhase 2 NCT07553299 Registry history of NCT07553299 on ClinicalTrials.gov (opens the registry)